Shelley Zieroth
LightNews LightNews
shelleyzieroth.bsky.social
Shelley Zieroth
@shelleyzieroth.bsky.social
590 followers 250 following 5 posts
Heart Function Cardiologist, ❤️ 🇨🇦 Professor. Past Pres Federation of Medical Women of 🇨🇦 + Canadian HF Society. Clinical trialist. Everything Cardio-Kidney-Metabolic. #cardiosky #medsky
Posts Replies Media Videos
Reposted by Shelley Zieroth
icardio.bsky.social
Join colleagues worldwide in our study on the perception and implementation of #IHD practice guidelines. Your input will help to guide the #iCARDIOAlliance as we develop new, globally relevant IHD guidelines. Survey link: icardioalliance.org

@shelleyzieroth.bsky.social

#cardiosky #medsky
November 3, 2025 at 12:12 PM
Reposted by Shelley Zieroth
ccs-scc.bsky.social
🚨 Just published! This guideline provides multi-disciplinary clinical teams with practical recommendations for SGLT2is, MRAs, ARNI and drugs with GLP-1 receptor agonist activity.

Read the guideline here: onlinecjc.ca/article/S082...

#Cardiosky #HeartFailure
October 20, 2025 at 2:00 PM
Reposted by Shelley Zieroth
hancardiomd.bsky.social
The invisible costs of heart failure: a societal toll

academic.oup.com/eurheartj/ad...

@escardio.bsky.social @cardioobdoc.bsky.social @shelleyzieroth.bsky.social @erinmichos.bsky.social @drmarthagulati.bsky.social
June 12, 2025 at 1:15 AM
Reposted by Shelley Zieroth
psatishmd.bsky.social
Kudos to this expert group on this comprehensive yet realistic guideline document!

Love the introduction of recommendations when resources are somewhat or severely limited.
#cardiosky #globalcardiology #globalhealth
May 2, 2025 at 2:15 PM
Reposted by Shelley Zieroth
icardio.bsky.social
Only a few hours left!
The iCARDIO Guidelines for CVD in Obesity close for public review today.
Help shape global strategies to address this urgent health crisis.

Submit feedback now: icardioalliance.org

#CVD #Obesity #Cardiology #PublicReview #GlobalHealth

@shelleyzieroth.bsky.social
June 2, 2025 at 8:10 AM
shelleyzieroth.bsky.social
Ecstatic to see these rapid HF GL come to open access! >50% of writers outside of Euro+NA with cascading rec's based on availability+accessibility. Global experts bring a concise 28pg simple HF GL!! More @icardio.bsky.social GL on obesity soon on the way. @fpinto1960.bsky.social #medsky #cardiosky
icardio.bsky.social iCardio @icardio.bsky.social · May 1
#iCARDIO Alliance has released its first Global Implementation Guidelines, focused on Acute & Chronic Heart Failure. This represents a significant advancement in equitable, evidence based cardiovascular care.
Read here - www.globalcardiology.info/site/issue/v...

#HeartFailure #cardiosky #medsky
May 1, 2025 at 5:58 PM
Reposted by Shelley Zieroth
hswapnil.medsky.social
Research letter in @jama.com on sema and tirze Rx for obesity in the US

The graph goes up and down from shortages mostly

interesting race/socioeconomic differences

jamanetwork.com/journals/jam...

#MedSky
Figure. Prescription Rates of Semaglutide and Tirzepatide for Obesity, Overall and by Race and Ethnicity, Social Vulnerability, and Urbanicity
April 29, 2025 at 8:28 PM
Reposted by Shelley Zieroth
hancardiomd.bsky.social
Gaps and Knowledge in the Contemporary Management of Acute Right Ventricular Failure

www.ahajournals.org/doi/10.1161/...

@ahascience.bsky.social #RVFailure #HeartFailure #CardioEd @cardioobdoc.bsky.social @shelleyzieroth.bsky.social @mmamas1973.bsky.social @mirvz.bsky.social
April 18, 2025 at 1:22 PM
Reposted by Shelley Zieroth
hancardiomd.bsky.social
#Aldosterone-targeted therapies: early implementation in resistant #HTN and #CKD

Reflecting on the fundamentals and exploring future directions

academic.oup.com/eurheartj/ad...
#CardioSky @escardio.bsky.social #EHJ @cardioobdoc.bsky.social @shelleyzieroth.bsky.social @drrajivsankar.bsky.social
April 13, 2025 at 4:19 PM
Reposted by Shelley Zieroth
hancardiomd.bsky.social
#Finerenone reduced the risk of CV death and total worsening HF events, and was well-tolerated, independent of glycaemic status in HFmrEF/HFpEF

@escardio.bsky.social @shelleyzieroth.bsky.social @drrajivsankar.bsky.social @docbhardwaj.bsky.social

onlinelibrary.wiley.com/doi/full/10....
Finerenone, glycaemic status, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS‐HF trial
Finerenone and glycaemic status in patients with heart failure with mildly reduced/preserved ejection fraction. CI, confidence interval; CV, cardiovascular; HF, heart failure; HR, hazard ratio; RR, r...
onlinelibrary.wiley.com
April 13, 2025 at 4:34 PM
Reposted by Shelley Zieroth
hancardiomd.bsky.social
New Dual Endothelin Receptor Antagonist Aprocitentan in Hypertension: A Systematic Review and Meta-Analysis

www.sciencedirect.com/science/arti...

#Aprocitentan #CardioSky @anastasiasmihaili.bsky.social @mmamas1973.bsky.social @cardioobdoc.bsky.social @shelleyzieroth.bsky.social
New Dual Endothelin Receptor Antagonist Aprocitentan in Hypertension: A Systematic Review and Meta-Analysis
Hypertension is one of the most common disorders encountered, yet pharmacotherapy for resistant hypertension has limited effective options. Aprocitent…
www.sciencedirect.com
April 10, 2025 at 12:19 AM
Reposted by Shelley Zieroth
hancardiomd.bsky.social
Lower extremity lymphatic flow is associated with diuretic response in acute heart failure

In 65 AHF patients, lymphatic flow (via ICG lymphangiography) predicted diuretic response.

#AHF #CardioSky #Lymphatics #AHF @shelleyzieroth.bsky.social @escardio.bsky.social @drrajivsankar.bsky.social
April 9, 2025 at 11:59 PM
Reposted by Shelley Zieroth
hancardiomd.bsky.social
Efficacy, Safety and Mechanistic Impact of a #HeartFailure Guideline-Directed Medical Therapy Clinic

#JACCHF #CardioSky #GDMT

www.jacc.org/doi/full/10....

@jimjanuzzi.bsky.social @jaccjournals.bsky.social @drmarthagulati.bsky.social @cardioobdoc.bsky.social @shelleyzieroth.bsky.social
April 9, 2025 at 11:50 PM
Reposted by Shelley Zieroth
hancardiomd.bsky.social
Prognostic value of left atrioventricular coupling index in heart failure

In 478 HF patients (LVEF <50%), higher #LACI (≥30.9%) was linked to worse outcomes.

academic.oup.com/ehjcimaging/... @escardio.bsky.social @cardioobdoc.bsky.social @vassv.bsky.social @shelleyzieroth.bsky.social
April 8, 2025 at 9:23 PM
Reposted by Shelley Zieroth
hancardiomd.bsky.social
Multicentre comparison of various microaxial pump devices as a bridge to durable assist device implantation

onlinelibrary.wiley.com/doi/10.1002/... #Impella #CardioSky #CardiogenicShock #LVADs
@drrajivsankar.bsky.social @shelleyzieroth.bsky.social @cardioobdoc.bsky.social @hvanspall.bsky.social
April 5, 2025 at 12:45 AM
Reposted by Shelley Zieroth
hancardiomd.bsky.social
Characterizing Heart Failure Across the Spectrum of the Preserved Ejection Fraction: Does HF With Supranormal EF Exist? Data From the 🇸🇪 #HeartFailure Registry

www.ahajournals.org/doi/10.1161/... @ahascience.bsky.social @gbiondizoccai.bsky.social @cardioobdoc.bsky.social @shelleyzieroth.bsky.social
March 27, 2025 at 8:51 PM
Reposted by Shelley Zieroth
hancardiomd.bsky.social
What's new in heart failure? March 2025

onlinelibrary.wiley.com/doi/full/10....
#EJHF #CardioSky @escardio.bsky.social @cardioobdoc.bsky.social @shelleyzieroth.bsky.social @drrajivsankar.bsky.social @erinmichos.bsky.social @novitham.bsky.social
April 3, 2025 at 10:56 PM
Reposted by Shelley Zieroth
hancardiomd.bsky.social
Ventricular arrhythmias in #AHF . A clinical consensus statement of the Association for Acute CardioVascular Care (#ACVC), #EHRA and the #HFA of the @escardio.bsky.social

onlinelibrary.wiley.com/doi/full/10....
#CardioSky @novitham.bsky.social @cardioobdoc.bsky.social @shelleyzieroth.bsky.social
March 23, 2025 at 8:26 PM
Reposted by Shelley Zieroth
hancardiomd.bsky.social
Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives
A scientific statement of the #HFA of @escardio.bsky.social

onlinelibrary.wiley.com/doi/full/10.... @shelleyzieroth.bsky.social @cardioobdoc.bsky.social @drrajivsankar.bsky.social #CardioSky
March 20, 2025 at 3:35 PM
Reposted by Shelley Zieroth
hancardiomd.bsky.social
Cardioprotective effects of #semaglutide on isolated human ventricular myocardium

onlinelibrary.wiley.com/doi/full/10....

#GLP1RA #CardioSky #EJHF @escardio.bsky.social @cardioobdoc.bsky.social @shelleyzieroth.bsky.social @drrajivsankar.bsky.social @vietheartpa.bsky.social
March 20, 2025 at 3:46 PM
Reposted by Shelley Zieroth
drmarthagulati.bsky.social
Today our opinion piece is in print @usatoday.com

NIH cuts will harm women’s heart research.
We cannot afford to go backwards.
Women’s heart health is not political.
@SmidtHeart @WomensHeartCS
#savingwomenshearts #womenshearthealth
📎 www.usatoday.com/story/opinio...
March 13, 2025 at 1:10 AM
Reposted by Shelley Zieroth
drmarthagulati.bsky.social
Thank you @barbrastreisand.bsky.social for fighting the fight with us
#womenshearthealth
February 22, 2025 at 1:27 AM
Reposted by Shelley Zieroth
drmarthagulati.bsky.social
Our joint publication with @jcardfail.bsky.social & @ajpcardio.bsky.social is out!
Underpinnings of #HeartFailure With Preserved Ejection Fraction in Women - From Prevention to Improving Function
#HFpEF #CVPrev #CardioTwitter #womenshearthealth #heartmonth
📎 onlinejcf.com/article/S107...
February 18, 2025 at 5:25 PM
Reposted by Shelley Zieroth
womenasone.bsky.social
🌟2025 Mentorship Awards applications are open - please share!

Elevate your career with 1-on-1 mentorship, check-ins with global leaders, and impactful scientific projects - all while expanding your professional network.

Apply today: womenasone.org/award...

#WomenAsOneAwards #CardioSky
February 17, 2025 at 6:00 PM
Reposted by Shelley Zieroth
escardio.bsky.social
Join international experts at #HeartFailure2025! 🌍

Discover cutting-edge science and gain fresh insights to elevate your practice.

Register by March 17 to save the most 👉
bit.ly/4hR37FO

#CardiologyResearch #HeartFailureResearch
February 12, 2025 at 4:10 PM